-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS: Covered Moderna for the first time and gave it a neutral rating. The target price was set at $34.

智通財經·01/07/2026 09:17:05
語音播報
UBS: Covered Moderna for the first time and gave it a neutral rating. The target price was set at $34.